Consensus Multilocus Sequence Typing Scheme for Pneumocystis jirovecii
Author
dc.contributor.author
Pasic, Lana
Author
dc.contributor.author
Goterris, Lidia
Author
dc.contributor.author
Guerrero Murillo, Mercedes
Author
dc.contributor.author
Irinyi, Laszlo
Author
dc.contributor.author
Kan, Alex
Author
dc.contributor.author
Ponce, Carolina A.
Author
dc.contributor.author
Vargas Munita, Sergio
Author
dc.contributor.author
Martín Gómez, M. Teresa
Author
dc.contributor.author
Meyer, Wieland
Admission date
dc.date.accessioned
2021-06-30T00:18:42Z
Available date
dc.date.available
2021-06-30T00:18:42Z
Publication date
dc.date.issued
2020
Cita de ítem
dc.identifier.citation
J. Fungi 2020, 6, 259
es_ES
Identifier
dc.identifier.other
10.3390/jof6040259
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/180330
Abstract
dc.description.abstract
Pneumocystis jirovecii is an opportunistic human pathogenic fungus causing severe pneumonia mainly in immunocompromised hosts. Multilocus sequence typing (MLST) remains the gold standard for genotyping of this unculturable fungus. However, the lack of a consensus scheme impedes a global comparison, large scale population studies and the development of a global MLST database. To overcome this problem this study compared all genetic regions (19 loci) currently used in 31 different published Pneumocystis MLST schemes. The most diverse/commonly used eight loci, beta-TUB, CYB, DHPS, ITS1, ITS1/2, mt26S and SOD, were further assess for their ability to be successfully amplified and sequenced, and for their discriminatory power. The most successful loci were tested to identify genetically related and unrelated cases. A new consensus MLST scheme consisting of four genetically independent loci: beta-TUB, CYB, mt26S and SOD, is herein proposed for standardised P. jirovecii typing, successfully amplifying low and high fungal burden specimens, showing adequate discriminatory power, and correctly identifying suspected related and unrelated isolates. The new consensus MLST scheme, if accepted, will for the first time provide a powerful tool to investigate outbreak settings and undertake global epidemiological studies shedding light on the spread of this important human fungal pathogen.
es_ES
Patrocinador
dc.description.sponsorship
National Health and Medical Research Council of Australia
APP1121936
National Fund for Science and Technology from Chile (Fondecyt-ANID)
1140412